Detalhe da pesquisa
1.
Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease.
Diabet Med
; 35(1): 72-77, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29057545
2.
Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
Diabet Med
; 34(9): 1284-1290, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28477414
3.
Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study.
Diabet Med
; 33(11): 1569-1574, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26887663
4.
Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Diabet Med
; 33(2): 224-30, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26043186
5.
The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Diabet Med
; 32(4): 459-66, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25439048
6.
Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial.
Diabet Med
; 32(8): 1090-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25818859
7.
Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Diabetes Obes Metab
; 17(4): 395-402, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600421
8.
Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
Diabet Med
; 31(2): 200-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24267048
9.
Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study.
Diabetes Obes Metab
; 16(12): 1265-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861892
10.
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
Diabetologia
; 56(9): 1925-33, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23793713
11.
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.
Diabetologia
; 55(10): 2593-2603, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875195
12.
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
Diabetologia
; 55(7): 1971-7, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22453232
13.
Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial.
Diabet Med
; 28(3): 363-72, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21309847
14.
Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study.
Diabet Med
; 28(5): 543-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480965
15.
Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.
Diabetes Obes Metab
; 13(12): 1136-41, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21767341
16.
Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.
Diabetologia
; 52(3): 394-7, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19048226
17.
Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses.
Diabetologia
; 52(10): 1990-2000, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19644668
18.
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.
Diabetologia
; 52(1): 50-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19002433
19.
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetologia
; 52(1): 17-30, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18941734
20.
Intensive glucose control and macrovascular outcomes in type 2 diabetes.
Diabetologia
; 52(11): 2288-98, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19655124